
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6423361
[patent_doc_number] => 20100167983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 12/660581
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5143
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12660581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/660581 | Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis | Feb 28, 2010 | Abandoned |
Array
(
[id] => 8625165
[patent_doc_number] => 08357660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-22
[patent_title] => 'Methods for inhibiting growth of prolactin-responsive cancer cells with cyclosporine A or other cyclophilin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/711580
[patent_app_country] => US
[patent_app_date] => 2010-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1374
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12711580
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/711580 | Methods for inhibiting growth of prolactin-responsive cancer cells with cyclosporine A or other cyclophilin inhibitors | Feb 23, 2010 | Issued |
Array
(
[id] => 7807245
[patent_doc_number] => 20120058199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'COMPOSITIONS, USE AND METHOD FOR THE USE OF SURFACE ACTIVE PROTEINS IN TOPICAL DRUG DELIVERY ACROSS KERATIN'
[patent_app_type] => utility
[patent_app_number] => 13/202112
[patent_app_country] => US
[patent_app_date] => 2010-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8358
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058199.pdf
[firstpage_image] =>[orig_patent_app_number] => 13202112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202112 | Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin | Feb 18, 2010 | Issued |
Array
(
[id] => 6640519
[patent_doc_number] => 20100227398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'Method for Mixing Object into Gelled Assembly'
[patent_app_type] => utility
[patent_app_number] => 12/705914
[patent_app_country] => US
[patent_app_date] => 2010-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5346
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20100227398.pdf
[firstpage_image] =>[orig_patent_app_number] => 12705914
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/705914 | Method for mixing object into gelled assembly | Feb 14, 2010 | Issued |
Array
(
[id] => 6563397
[patent_doc_number] => 20100272817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'Compositions and Methods for Treating Atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 12/701753
[patent_app_country] => US
[patent_app_date] => 2010-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10974
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272817.pdf
[firstpage_image] =>[orig_patent_app_number] => 12701753
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/701753 | Compositions and Methods for Treating Atherosclerosis | Feb 7, 2010 | Abandoned |
Array
(
[id] => 6637269
[patent_doc_number] => 20100173849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'NEO-TRYPTOPHAN'
[patent_app_type] => utility
[patent_app_number] => 12/651878
[patent_app_country] => US
[patent_app_date] => 2010-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16533
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173849.pdf
[firstpage_image] =>[orig_patent_app_number] => 12651878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/651878 | NEO-TRYPTOPHAN | Jan 3, 2010 | Abandoned |
Array
(
[id] => 6236255
[patent_doc_number] => 20100267628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/651839
[patent_app_country] => US
[patent_app_date] => 2010-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 7145
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12651839
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/651839 | Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes | Jan 3, 2010 | Abandoned |
Array
(
[id] => 6162977
[patent_doc_number] => 20110160143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'Topical Acyl Glutathione Psoriasis Compositions'
[patent_app_type] => utility
[patent_app_number] => 12/647622
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3568
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160143.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647622
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647622 | Topical Acyl Glutathione Psoriasis Compositions | Dec 27, 2009 | Abandoned |
Array
(
[id] => 6162985
[patent_doc_number] => 20110160144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'Topical Acyl Glutathione Formulations'
[patent_app_type] => utility
[patent_app_number] => 12/647629
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3249
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160144.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647629
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647629 | Topical Acyl Glutathione Formulations | Dec 27, 2009 | Abandoned |
Array
(
[id] => 6295268
[patent_doc_number] => 20100160232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'PHYSIOLOGICALLY ACTIVE COMPLEX COMPRISING PROTAMINE AND/OR SALT THEREOF AND AN ACIDIC MACROMOLECULAR SUBSTANCE, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/647049
[patent_app_country] => US
[patent_app_date] => 2009-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13019
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160232.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647049
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647049 | Physiologically active complex comprising protamine and/or salt therefor and an acidic macromolecular substance, and use thereof | Dec 23, 2009 | Issued |
Array
(
[id] => 6295214
[patent_doc_number] => 20100160214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'DESMOPRESSIN COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/644127
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10630
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12644127
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/644127 | DESMOPRESSIN COMPOSITION | Dec 21, 2009 | Abandoned |
Array
(
[id] => 8577702
[patent_doc_number] => 08343912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Antibiotic compositions for the treatment of gram negative infections'
[patent_app_type] => utility
[patent_app_number] => 12/644943
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16675
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12644943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/644943 | Antibiotic compositions for the treatment of gram negative infections | Dec 21, 2009 | Issued |
Array
(
[id] => 6136264
[patent_doc_number] => 20110009343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'MODULATORS OF AMYLOID AGGREGATION'
[patent_app_type] => utility
[patent_app_number] => 12/643258
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 37541
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009343.pdf
[firstpage_image] =>[orig_patent_app_number] => 12643258
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/643258 | MODULATORS OF AMYLOID AGGREGATION | Dec 20, 2009 | Abandoned |
Array
(
[id] => 8675032
[patent_doc_number] => 08383144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'Tissue adhering compositions'
[patent_app_type] => utility
[patent_app_number] => 12/641215
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8380
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12641215
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/641215 | Tissue adhering compositions | Dec 16, 2009 | Issued |
Array
(
[id] => 8896258
[patent_doc_number] => 08475779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Methods of treating disease with random copolymers'
[patent_app_type] => utility
[patent_app_number] => 12/637723
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 25541
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12637723
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/637723 | Methods of treating disease with random copolymers | Dec 13, 2009 | Issued |
Array
(
[id] => 7696166
[patent_doc_number] => 20110230424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'OPHTHALMIC SOLUTIONS, INCLUDING CONTACT LENS CARE AND EYE DROPS COMPRISING CARNOSINE, PREFERABLY IN COMBINATION WITH DEXPANTHENOL AND/OR HYALURONIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/129709
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9423
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230424.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129709
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129709 | OPHTHALMIC SOLUTIONS, INCLUDING CONTACT LENS CARE AND EYE DROPS COMPRISING CARNOSINE, PREFERABLY IN COMBINATION WITH DEXPANTHENOL AND/OR HYALURONIC ACID | Nov 16, 2009 | Abandoned |
Array
(
[id] => 7663630
[patent_doc_number] => 20110312899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'HDL Particles for Delivery of Nucleic Acids'
[patent_app_type] => utility
[patent_app_number] => 13/129349
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23128
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312899.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129349
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129349 | HDL particles for delivery of nucleic acids | Nov 16, 2009 | Issued |
Array
(
[id] => 6536630
[patent_doc_number] => 20100124567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-20
[patent_title] => 'STABILIZING ALKYLGLYCOSIDE COMPOSITIONS AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/618558
[patent_app_country] => US
[patent_app_date] => 2009-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 24176
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20100124567.pdf
[firstpage_image] =>[orig_patent_app_number] => 12618558
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/618558 | Stabilizing alkylglycoside compositions and methods thereof | Nov 12, 2009 | Issued |
Array
(
[id] => 8701385
[patent_doc_number] => 08394606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => 'Neutrophil gelatinase-associated lipocalin (NGAL) protein isoforms enriched from urine and recombinant chinese hamster ovary (CHO) cells and related compositions, antibodies, and methods of enrichment, analysis and use'
[patent_app_type] => utility
[patent_app_number] => 12/612061
[patent_app_country] => US
[patent_app_date] => 2009-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29841
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12612061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/612061 | Neutrophil gelatinase-associated lipocalin (NGAL) protein isoforms enriched from urine and recombinant chinese hamster ovary (CHO) cells and related compositions, antibodies, and methods of enrichment, analysis and use | Nov 3, 2009 | Issued |
Array
(
[id] => 7580855
[patent_doc_number] => 20110294738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'PTHR1 RECEPTOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/127694
[patent_app_country] => US
[patent_app_date] => 2009-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17697
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294738.pdf
[firstpage_image] =>[orig_patent_app_number] => 13127694
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127694 | PTHR1 RECEPTOR COMPOUNDS | Nov 3, 2009 | Abandoned |